A 2026 case report documents an Alzheimer's patient regaining speech after a single dose during one groundbreaking drug trial ...
A woman with advanced Alzheimer's reportedly showed significant brain function improvements after taking psilocybin mushrooms ...
What a trip. After a decade of cognitive and functional decline, an 80-year-old patient with advanced Alzheimer’s disease ...
Millions of Americans take glucosamine daily for joint pain, but a large electronic health records analysis from the ...
Researchers discovered that mutations linked to blood cancers may help trigger Alzheimer’s disease by creating overly ...
A major study suggests glucosamine, a popular supplement for joint pain, could be linked to faster progression from mild ...
Phase 2a study will evaluate the safety and biological activity of leronlimab in patients over the age of 50 with early-stage, biomarker-confirmed Alzheimer’s disease VANCOUVER, Washington, June 11, ...
The head of the Osceola Council on Aging details help available for patients and caregivers in her county and across the region.
Glucosamine tied to faster progression in people with established neurodegeneration ...
Karen’s mother has Alzheimer’s disease, and the family has reached the point where living independently is no longer an ...
Popular joint supplement glucosamine may speed Alzheimer's progression, raising urgent questions for millions.